pargyline has been researched along with Psychotic Disorders in 5 studies
Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SUTNICK, AI | 1 |
| WEISS, LB | 1 |
| SCHINDLER, PD | 1 |
| SOLOFF, LA | 1 |
| SHARPLEY, P | 1 |
| MENA, A | 1 |
| SCHIELE, BC | 1 |
| HEISTAD, G | 1 |
| MCCURDY, RL | 1 |
| KAN, FJ | 1 |
| TURNER, WJ | 1 |
| MERLIS, S | 1 |
| Bucci, L | 1 |
5 other studies available for pargyline and Psychotic Disorders
| Article | Year |
|---|---|
PSYCHOTIC REACTIONS DURING THERAPY WITH PARGYLINE.
Topics: Aged; Antihypertensive Agents; Geriatrics; Humans; Hypotension; Hypotension, Orthostatic; Monoamine | 1964 |
A COMPARISON OF PARGYLINE AND TRANYLCYPROMINE WITH AND WITHOUT THE ADDITION OF TRIFLUOPERAZINE: A DOUBLE-BLIND STUDY.
Topics: Biomedical Research; Brain; Brain Damage, Chronic; Depressive Disorder, Major; Double-Blind Method; | 1964 |
TRANSIENT BRAIN SYNDROME AS A NON-FATAL REACTION TO COMBINED PARGYLINE-IMIPRAMINE TREATMENT.
Topics: Brain; Depression; Depressive Disorder; Drug Therapy; Geriatrics; Hypertension; Imipramine; Mental D | 1964 |
A CLINICAL TRIAL OF PARGYLINE AND DOPA IN PSYCHOTIC SUBJECTS.
Topics: Adolescent; Biomedical Research; Brain; Brain Damage, Chronic; Depression; Depressive Disorder, Majo | 1964 |
The mono-amine oxidase inhibitors; their usefulness and their safety.
Topics: Adolescent; Adult; Chlorpromazine; Drug Synergism; Female; Humans; Middle Aged; Monoamine Oxidase In | 1969 |